SARAJEVO (Bosnia and Herzegovina), August 17 (SeeNews) – The shares of Bosnia's top drug maker Bosnalijek gained almost 3.0% by noon on Tuesday after its U.S. peer Alvogen said a day earlier it was in final talks to buy the state’s minority stake in the company, brokers said.